Literature DB >> 7980412

The intracellular distribution of inositol polyphosphates in HL60 promyeloid cells.

J A Stuart1, K L Anderson, P J French, C J Kirk, R H Michell.   

Abstract

1. HL60 promyeloid cells contain high intracellular concentrations of inositol polyphosphates, notably inositol 1,3,4,5,6-pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6). To determine their intracellular location(s), we studied the release of inositol (poly)phosphates, of ATP, and of cytosolic and granule-enclosed enzymes from cells permeabilized by four different methods. 2. When cells were treated with digitonin, all of the inositol phosphates were released in parallel with the cytosolic constituents. Most of the InsP5 and InsP6 was released before significant permeabilization of azurophil granules. 3. Similar results were obtained from cells preloaded with ethylene glycol and permeabilized by osmotic lysis. 4. Electroporation at approximately 500 V/cm caused rapid release of free inositol. Higher field strengths provoked release of most of the ATP, InsP5 and InsP6, but only slight release of the intracellular enzymes. Multiple discharges released approximately 80-90% of total InsP5 and InsP6. In the absence of bivalent-cation chelators, InsP5 and InsP6 were released less readily than ATP. 5. Treatment of cells with Staphylococcus aureus alpha-toxin caused quantitative release of inositol and ATP, without release of intracellular enzymes. However, inositol phosphates were released much less readily than inositol or ATP. Even after prolonged incubation with a high concentration of alpha-toxin, only approximately 50-70% of InsP2, InsP3 and InsP4 and < or = 20% of InsP5 and InsP6 were released, indicating that the high charge or large hydrated radius of InsP5 and InsP6 might limit their release through small toxin-induced pores. 6. These results indicate that most intracellular inositol metabolites are either in, or in rapid exchange with, the cytosolic compartment of HL60 cells. However, they leave open the possibility that a small proportion of cellular InsP5 and InsP6 (< or = 10-20%) might be in some intracellular bound form.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980412      PMCID: PMC1137358          DOI: 10.1042/bj3030517

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Inositol hexakisphosphate stimulates 45Ca2+ uptake in anterior pituitary cells in culture.

Authors:  M A Sortino; F Nicoletti; P L Canonico
Journal:  Eur J Pharmacol       Date:  1990-07-31       Impact factor: 4.432

2.  Phytic acid. A natural antioxidant.

Authors:  E Graf; K L Empson; J W Eaton
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

3.  Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum.

Authors:  R A Challiss; A L Willcocks; B Mulloy; B V Potter; S R Nahorski
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

4.  Inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate inhibit inositol-1,3,4,5-tetrakisphosphate 3-phosphatase in rat parotid glands.

Authors:  P J Hughes; S B Shears
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

5.  Relationship between the calcium-mobilizing action of inositol 1,4,5-trisphosphate in permeable AR4-2J cells and the estimated levels of inositol 1,4,5-trisphosphate in intact AR4-2J cells.

Authors:  G J Bird; K G Oliver; D A Horstman; J Obie; J W Putney
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

6.  Cardiorespiratory effects of inositol hexakisphosphate following microinjections into the nucleus tractus solitarii.

Authors:  R A Barraco; J W Phillis; L L Simpson
Journal:  Eur J Pharmacol       Date:  1989-11-28       Impact factor: 4.432

7.  Pharmacologic differentiation between inositol-1,4,5-trisphosphate-induced Ca2+ release and Ca2+- or caffeine-induced Ca2+ release from intracellular membrane systems.

Authors:  P Palade; C Dettbarn; B Alderson; P Volpe
Journal:  Mol Pharmacol       Date:  1989-10       Impact factor: 4.436

8.  Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain.

Authors:  M Vallejo; T Jackson; S Lightman; M R Hanley
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

9.  Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.

Authors:  F Nicoletti; V Bruno; S Cavallaro; A Copani; M A Sortino; P L Canonico
Journal:  Mol Pharmacol       Date:  1990-05       Impact factor: 4.436

10.  Inositol phosphate metabolism in bradykinin-stimulated human A431 carcinoma cells. Relationship to calcium signalling.

Authors:  B C Tilly; P A van Paridon; I Verlaan; K W Wirtz; S W de Laat; W H Moolenaar
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

View more
  17 in total

1.  Targeted deletion of Minpp1 provides new insight into the activity of multiple inositol polyphosphate phosphatase in vivo.

Authors:  H Chi; X Yang; P D Kingsley; R J O'Keefe; J E Puzas; R N Rosier; S B Shears; P R Reynolds
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 2.  How versatile are inositol phosphate kinases?

Authors:  Stephen B Shears
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 3.  Defining signal transduction by inositol phosphates.

Authors:  Stephen B Shears; Sindura B Ganapathi; Nikhil A Gokhale; Tobias M H Schenk; Huanchen Wang; Jeremy D Weaver; Angelika Zaremba; Yixing Zhou
Journal:  Subcell Biochem       Date:  2012

4.  Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites.

Authors:  Dan E McNamara; Cole M Dovey; Andrew T Hale; Giovanni Quarato; Christy R Grace; Cristina D Guibao; Jonathan Diep; Amanda Nourse; Casey R Cai; Hong Wu; Ravi C Kalathur; Douglas R Green; John D York; Jan E Carette; Tudor Moldoveanu
Journal:  Cell Chem Biol       Date:  2019-04-25       Impact factor: 8.116

5.  Inositide evolution - towards turtle domination?

Authors:  Robin F Irvine
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

6.  myo-Inositol hexakisphosphate is a major component of an extracellular structure in the parasitic cestode Echinococcus granulosus.

Authors:  Florencia Irigoín; Fernando Ferreira; Cecilia Fernández; Robert B Sim; Alvaro Díaz
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

7.  Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors.

Authors:  E Kitchen; A M Condliffe; A G Rossi; C Haslett; E R Chilvers
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

8.  Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.

Authors:  Christopher J Barker; Joanne Wright; Philip J Hughes; Christopher J Kirk; Robert H Michell
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 9.  Inositol polyphosphates: a new frontier for regulating gene expression.

Authors:  Abel R Alcázar-Román; Susan R Wente
Journal:  Chromosoma       Date:  2007-10-18       Impact factor: 4.316

10.  Purified inositol hexakisphosphate kinase is an ATP synthase: diphosphoinositol pentakisphosphate as a high-energy phosphate donor.

Authors:  S M Voglmaier; M E Bembenek; A I Kaplin; G Dormán; J D Olszewski; G D Prestwich; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.